...
首页> 外文期刊>Frontiers in Microbiology >Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii
【24h】

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii

机译:凝集素Scytovirin的新型抗真菌活性:抑制新隐球菌隐球菌加蒂

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Pathogenic cryptococci are encapsulated yeast that can cause severe meningoencephalitis. Existing therapeutic options are dated and there is a growing need for new alternative antifungal agents for these fungi. Here we report novel inhibition of pathogenic cryptococci by the antimicrobial lectin Scytovirin. Inhibition was most potent against Cryptococcus neoformans var neoformans and C. gattii , with MFC values of 500 nM. Scytovirin binding was localized to the cell wall and shown to affect capsule size and release. No effect was observed on melanization or with cells grown in the presence the cell wall stressor Congo red. Synergy with existing antifungals was indicated, most strongly for amphotericin B. Overall, Scytovirin serves as a much needed new avenue for anticryptococcal development.
机译:致病性隐球菌是封装的酵母,可引起严重的脑膜脑炎。现有的治疗选择已经过时,并且对于这些真菌的新的替代抗真菌剂的需求日益增长。在这里,我们报告了抗菌素凝集素Scytovirin对病原性隐球菌的新抑制作用。抑制作用最有效的是新隐球菌,新形变种和加氏梭菌,MFC值为500 nM。 Scytovirin结合被定位到细胞壁,并显示影响胶囊大小和释放。没有观察到对黑色素化或在细胞壁应激物刚果红存在下生长的细胞的影响。已表明与现有抗真菌剂具有协同作用,其中最强的是两性霉素B。总体而言,Scytovirin是抗隐球菌发展的急需新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号